{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:58:46Z","timestamp":1791295126416,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.molimm.2013.05.242","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T22:32:00Z","timestamp":1375396320000},"page":"549-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Activation of complement by monoclonal antibodies that target cell-associated \u03b22-microglobulin: Implications for cancer immunotherapy"],"prefix":"10.1016","volume":"56","author":[{"given":"Michael J.","family":"Pokrass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica F.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Lindorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2013.05.242_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","article-title":"Production of monoclonal antibodies to Group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis","volume":"14","author":"Barnstable","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2013.05.242_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2004.03.012","article-title":"Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas","volume":"289","author":"Beum","year":"2004","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.molimm.2013.05.242_bib0015","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.176.4.2600","article-title":"The shaving reaction: Rituximab\/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes","volume":"176","author":"Beum","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.181.1.822","article-title":"Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis","volume":"181","author":"Beum","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0025","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/eji.201041204","article-title":"Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca2+ influx and induces streamers","volume":"41","author":"Beum","year":"2011","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0030","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.4049\/jimmunol.181.4.2916","article-title":"Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving","volume":"181","author":"Beum","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0035","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.4049\/jimmunol.181.11.8120","article-title":"Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes","volume":"181","author":"Beum","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0040","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.160.7.3437","article-title":"A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement","volume":"160","author":"Blok","year":"1998","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0045","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1182\/blood-2006-04-020057","article-title":"Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab","volume":"108","author":"Bowles","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0050","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/eji.1830090709","article-title":"Characterization of a monoclonal anti-beta2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens","volume":"9","author":"Brodsky","year":"1979","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2011.08714.x","article-title":"Targeting cell surface \u03b22-microglobulin by pentameric IgM antibodies","volume":"154","author":"Cao","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0076-6879(95)54029-6","article-title":"Monoclonal antibodies to oncoproteins","volume":"254","author":"Chang","year":"1995","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/immu.200310028","article-title":"Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59","volume":"33","author":"Clayton","year":"2003","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/clim.2002.5266","article-title":"Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages","volume":"105","author":"Craig","year":"2002","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.20012024","article-title":"Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody","volume":"195","author":"da Silveira","year":"2002","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.molimm.2013.05.242_bib0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/j.1460-2075.1988.tb03037.x","article-title":"Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies","volume":"7","author":"Dangl","year":"1988","journal-title":"EMBO Journal"},{"key":"10.1016\/j.molimm.2013.05.242_bib0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1423-0410.2000.7920108.x","article-title":"HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody","volume":"79","author":"Datema","year":"2000","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.molimm.2013.05.242_bib0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"del Conde","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.molimm.2013.05.242_bib0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0145-2126(97)00191-4","article-title":"Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia","volume":"22","author":"Estrov","year":"1998","journal-title":"Leukemia Research"},{"key":"10.1016\/j.molimm.2013.05.242_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.abb.2012.02.011","article-title":"Mechanism of action of therapeutic monoclonal antibodies. Promises and pitfalls of in vitro and in vivo assays","volume":"526","author":"Golay","year":"2012","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.molimm.2013.05.242_bib0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4049\/jimmunol.166.2.1057","article-title":"Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia","volume":"166","author":"Hahn","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0115","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.0902810","article-title":"Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor I","volume":"184","author":"Hamad","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-1759(02)00207-7","article-title":"Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions","volume":"268","author":"Harris","year":"2002","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.molimm.2013.05.242_bib0125","first-page":"100","article-title":"The death of human platelets during incubation in citrated plasma involves shedding of CD42b and aggregation of dead platelets","volume":"95","author":"Hartley","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.molimm.2013.05.242_bib0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/09537100600760822","article-title":"Hypoglycaemia predisposes platelets to death by affecting calcium homeostasis and mitochondrial integrity","volume":"18","author":"Hartley","year":"2007","journal-title":"Platelets"},{"key":"10.1016\/j.molimm.2013.05.242_bib0135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molimm.2013.05.242_bib0140","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1074\/jbc.M109.092759","article-title":"Androgen receptor survival signaling is blocked by anti-\u03b22-microglobulin monoclonal antibody via a MAPK\/lipogenic pathway in human prostrate cancer cells","volume":"285","author":"Huang","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molimm.2013.05.242_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cryobiol.2011.01.003","article-title":"Cryopreservation of buffy-coat derived platelet concentrations in dimethyl sulfoxide and platelet additive solution","volume":"62","author":"Johnson","year":"2011","journal-title":"Cryobiology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0150","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-10-3382","article-title":"\u03b22-Microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells","volume":"71","author":"Josson","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/j.molimm.2013.05.242_bib0155","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V68.3.627.627","article-title":"Quantitative analysis of platelet surface HLA by W6\/32 anti-HLA monoclonal antibody","volume":"68","author":"Kao","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0160","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.4049\/jimmunol.172.5.3280","article-title":"Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia","volume":"172","author":"Kennedy","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2002-03-0876","article-title":"An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by Rituximab","volume":"101","author":"Kennedy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0170","first-page":"687","article-title":"Activation of mouse complement by different classes of mouse antibody","volume":"38","author":"Klaus","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0175","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.4049\/jimmunol.170.7.3671","article-title":"The B cell complement receptor 2 transfer reaction","volume":"170","author":"Lindorfer","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4161\/onci.20368","article-title":"Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?","volume":"1","author":"Lindorfer","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0185","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood-2007-09-113373","article-title":"The yin and yang of Fc\u03b3 receptors in ITP","volume":"111","author":"McKenzie","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0190","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/TP.0b013e3182669129","article-title":"Antibody alone is not a stimulator of exocytosis of Weibel\u2013Palade bodies from human endothelial cells","volume":"94","author":"Meli","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.molimm.2013.05.242_bib0195","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2008-01-135160","article-title":"Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc\u03b3RI, Fc\u03b3RIII and Fc\u03b3RIV","volume":"112","author":"Minard-Colin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"Najaoui","year":"2012","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0205","first-page":"32","article-title":"MHC class I molecules, structure and function","volume":"1","author":"Natarajan","year":"1999","journal-title":"Reviews in Immunogenetics"},{"key":"10.1016\/j.molimm.2013.05.242_bib0210","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/eji.1830111212","article-title":"Activation of mouse complement by monoclonal mouse antibodies","volume":"11","author":"Neuberger","year":"1981","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.coi.2007.01.005","article-title":"Antibodies, Fc receptors and cancer","volume":"19","author":"Nimmerjahn","year":"2007","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/307136a0","article-title":"Correlation between segmental flexibility and effector function of antibodies","volume":"307","author":"Oi","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2013.05.242_bib0225","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.4049\/jimmunol.1200356","article-title":"Crosstalk between human IgG isotypes and murine effector cells","volume":"189","author":"Overdijk","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0230","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","article-title":"Complement activation on platelets. Implication for vascular inflammation and thrombosis","volume":"47","author":"Peerschke","year":"2010","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0235","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2006.02065.x","article-title":"Blood platelets activate the classical pathway of human complement","volume":"4","author":"Peerschke","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.molimm.2013.05.242_bib0240","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.178.2.579","article-title":"Platelet activation by C1q results in the induction of \u03b1IIb\/\u03b23 Integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity","volume":"178","author":"Peerschkle","year":"1993","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.molimm.2013.05.242_bib0245","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0250","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/biot.200800110","article-title":"Novel human antibody therapeutics: the age of the Umabs","volume":"3","author":"Ruuls","year":"2008","journal-title":"Biotechnology Journal"},{"key":"10.1016\/j.molimm.2013.05.242_bib0255","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1100319","article-title":"A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome","volume":"188","author":"Sartz","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0260","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1182\/blood-2004-05-1886","article-title":"Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg","volume":"105","author":"Song","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0265","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2007-08-106153","article-title":"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation","volume":"111","author":"Stahl","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0270","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncprheum0424","article-title":"Drug Insight: the mechanism of action of rituximab in autoimmune disease\u2014the immune complex decoy hypothesis","volume":"3","author":"Taylor","year":"2007","journal-title":"Nature Clinical Practice Rheumatology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0275","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.coi.2008.05.011","article-title":"Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies","volume":"20","author":"Taylor","year":"2008","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0280","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.4049\/jimmunol.159.8.4035","article-title":"Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model","volume":"159","author":"Taylor","year":"1997","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0285","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2004-01-0039","article-title":"Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin's lymphomas","volume":"104","author":"Teeling","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0290","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/10428190902755497","article-title":"Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes","volume":"50","author":"Vikentiou","year":"2009","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.molimm.2013.05.242_bib0295","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","article-title":"Rituximab: mechanism of action","volume":"47","author":"Weiner","year":"2010","journal-title":"Seminars in Hematology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2006.02.032","article-title":"Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys","volume":"44","author":"Whipple","year":"2007","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0305","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.4049\/jimmunol.177.10.7435","article-title":"Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia","volume":"177","author":"Williams","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.molimm.2013.05.242_bib0310","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1158\/1078-0432.CCR-08-1823","article-title":"Human-like mouse models for testing the efficacy and safety of anti-\u03b22-microglobulin monoclonal antibodies to treat myeloma","volume":"15","author":"Yang","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.molimm.2013.05.242_bib0315","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ccr.2006.08.025","article-title":"Targeting \u03b22-microglobulin for induction of tumor apoptosis in human hematological malignancies","volume":"10","author":"Yang","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molimm.2013.05.242_bib0320","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/cncr.24953","article-title":"Killing tumor cells through their surface \u03b22-microglobulin or major histocompatibility complex class I molecules","volume":"116","author":"Yang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.molimm.2013.05.242_bib0325","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2007-06-094417","article-title":"Anti-\u03b22-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2013.05.242_bib0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.leukres.2003.09.011","article-title":"Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium","volume":"28","author":"Zent","year":"2004","journal-title":"Leukemia Research"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013004215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589013004215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T16:33:16Z","timestamp":1688401996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589013004215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0161589013004215"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2013.05.242","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of complement by monoclonal antibodies that target cell-associated \u03b22-microglobulin: Implications for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2013.05.242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}